Americans look to Canada for lower drug prices, but are they getting the full picture?: Nigel Rawson and John Adams in The Hill
This article originally appeared in The Hill. The full article can be read here. By Nigel Rawson and John Adams, ...
Tag: drug policy
Waiting for new drugs for rare disorders in Canada, part 5 – Patented Medicine Prices Review Board: Nigel Rawson and John Adams for Inside Policy
This article is the fifth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada, part 4 – government drug plan listing: Nigel Rawson and John Adams for Inside Policy
This article is the fourth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada – part 3, price negotiation: Nigel Rawson and John Adams for Inside Policy
This article is the third part of an 8-part series from the authors. The series, Waiting for new drugs for ...
Waiting for new drugs for rare disorders in Canada – part 2, health technology assessment: Nigel Rawson and John Adams for Inside Policy
This article is the second part of an 8-part series from the authors. The series, Waiting for new drugs for ...
-
Unfortunately for Canadian consumers and creators, the Online Streaming Act is performing exactly as predicted: Peter Menzies in the Hub
-
Mexican cartels are a direct threat to Canada’s public safety, and the future of North American trade: Gary J. Hale for Inside Policy
-
Canadians are very unhappy with the federal public service—and for good reason: Tim Sargent in The Hub
-
An economist on Ottawa’s GST holiday. Spoiler alert – Santa Claus is not real: Tim Sargent in the Globe and Mail
-
Canada is an energy superpower. It’s time to remind America and act like it: Heather Exner-Pirot in The Hub
